Integrin β 3 crosstalk with VEGFR accommodating tyrosine phosphorylation as a regulatory switch

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  West, Xiaoxia Z ^a   Meller, Nahum ^a   Malinin, Nikolay L ^a   Deshmukh, Lalit ^b,c   Meller, Julia ^a   Mahabeleshwar, Ganapati H ^a,d   Weber, Malory E ^a   Kerr, Bethany A ^a   Vinogradova, Olga ^b   Byzova, Tatiana V ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; FIBROBLAST GROWTH FACTOR RECEPTOR; PHENYLALANINE; TYROSINE; VASCULOTROPIN RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDE; PHOSPHOTYROSINE; VASCULOTROPIN A;

ALPHA HELIX; AMINO ACID SUBSTITUTION; ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; REGULATOR GENE; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; CHEMISTRY; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; METABOLISM; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORYLATION; UMBILICAL VEIN ENDOTHELIAL CELL;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTEGRIN BETA3; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDES; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN BINDING; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84857159984     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031071     Document Type: Article

References (41)

1. Hynes RO, (1987) Integrins: a family of cell surface receptors. Cell 48: 549-554.
2. Hynes RO, (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687.
3. Ma YQ, Qin J, Plow EF, (2007) Platelet integrin alpha(IIb)beta(3): activation mechanisms. J Thromb Haemost 5: 1345-1352.
4. Calderwood DA, Zent R, Grant R, Rees DJ, Hynes RO, et al. (1999) The Talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation. J Biol Chem 274: 28071-28074.
5. Vinogradova O, Velyvis A, Velyviene A, Hu B, Haas T, et al. (2002) A structural mechanism of integrin alpha(IIb)beta(3) "inside-out" activation as regulated by its cytoplasmic face. Cell 110: 587-597.
6. Anthis NJ, Haling JR, Oxley CL, Memo M, Wegener KL, et al. (2009) {beta} integrin tyrosine phosphorylation is a conserved mechanism for regulating talin-induced integrin activation. J Biol Chem 284: 36700-36710.
7. Cowan KJ, Law DA, Phillips DR, (2000) Identification of shc as the primary protein binding to the tyrosine-phosphorylated beta 3 subunit of alpha IIbbeta 3 during outside-in integrin platelet signaling. J Biol Chem 275: 36423-36429.
8. Phillips DR, Nannizzi-Alaimo L, Prasad KS, (2001) Beta3 tyrosine phosphorylation in alphaIIbbeta3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling. Thromb Haemost 86: 246-258.
9. Deshmukh L, Gorbatyuk V, Vinogradova O, (2010) Integrin beta3 phosphorylation dictates its complex with Shc PTB domain. J Biol Chem 285: 34875-34884.
10. Blystone SD, Williams MP, Slater SE, Brown EJ, (1997) Requirement of integrin beta3 tyrosine 747 for beta3 tyrosine phosphorylation and regulation of alphavbeta3 avidity. J Biol Chem 272: 28757-28761.
11. Boettiger D, Huber F, Lynch L, Blystone S, (2001) Activation of alpha(v)beta3-vitronectin binding is a multistage process in which increases in bond strength are dependent on Y747 and Y759 in the cytoplasmic domain of beta3. Mol Biol Cell 12: 1227-1237.
12. Chandhoke SK, Williams M, Schaefer E, Zorn L, Blystone SD, (2004) Beta 3 integrin phosphorylation is essential for Arp3 organization into leukocyte alpha V beta 3-vitronectin adhesion contacts. J Cell Sci 117: 1431-1441.
13. Butler B, Williams MP, Blystone SD, (2003) Ligand-dependent activation of integrin alpha vbeta 3. J Biol Chem 278: 5264-5270.
14. Datta A, Huber F, Boettiger D, (2002) Phosphorylation of beta3 integrin controls ligand binding strength. J Biol Chem 277: 3943-3949.
15. Byzova TV, Goldman CK, Pampori N, Thomas KA, Bett A, et al. (2000) A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol Cell 6: 851-860.
16. Mahabeleshwar GH, Feng W, Reddy K, Plow EF, Byzova TV, (2007) Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis. Circ Res 101: 570-580.
17. Soldi R, Mitola S, Strasly M, Defilippi P, Tarone G, et al. (1999) Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 18: 882-892.
18. Mahabeleshwar GH, Feng W, Phillips DR, Byzova TV, (2006) Integrin signaling is critical for pathological angiogenesis. J Exp Med 203: 2495-2507.
19. Napione L, Cascone I, Mitola S, Serini G, Bussolino F, (2007) Integrins: a flexible platform for endothelial vascular tyrosine kinase receptors. Autoimmun Rev 7: 18-22.
20. Serini G, Valdembri D, Bussolino F, (2006) Integrins and angiogenesis: a sticky business. Exp Cell Res 312: 651-658.
21. Byzova TV, Kim W, Midura RJ, Plow EF, (2000) Activation of integrin alpha(V)beta(3) regulates cell adhesion and migration to bone sialoprotein. Exp Cell Res 254: 299-308.
22. Mahabeleshwar GH, Chen J, Feng W, Somanath PR, Razorenova OV, et al. (2008) Integrin affinity modulation in angiogenesis. Cell Cycle 7: 335-347.
23. Vaynberg J, Qin J, (2006) Weak protein-protein interactions as probed by NMR spectroscopy. Trends Biotechnol 24: 22-27.
24. Leppanen VM, Prota AE, Jeltsch M, Anisimov A, Kalkkinen N, et al. (2010) Structural determinants of growth factor binding and specificity by VEGF receptor 2. Proc Natl Acad Sci U S A 107: 2425-2430.
25. Harris PA, Cheung M, Hunter RN III, Brown ML, Veal JM, et al. (2005) Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitors. J Med Chem 48: 1610-1619.
26. Deshmukh L, Gorbatyuk V, Vinogradova O, (2010) Integrin {beta}3 phosphorylation dictates its complex with the Shc phosphotyrosine-binding (PTB) domain. The Journal of biological chemistry 285: 34875-34884.
27. Deshmukh L, Meller N, Alder N, Byzova T, Vinogradova O, (2011) Tyrosine Phosphorylation as a Conformational Switch: A CASE STUDY OF INTEGRIN beta3 CYTOPLASMIC TAIL. The Journal of biological chemistry 286: 40943-40953.
28. Davis GE, Stratman AN, Sacharidou A, Koh W, (2011) Molecular basis for endothelial lumen formation and tubulogenesis during vasculogenesis and angiogenic sprouting. International review of cell and molecular biology 288: 101-165.
29. Law DA, DeGuzman FR, Heiser P, Ministri-Madrid K, Killeen N, et al. (1999) Integrin cytoplasmic tyrosine motif is required for outside-in alphaIIbbeta3 signalling and platelet function. Nature 401: 808-811.
30. Reynolds LE, Wyder L, Lively JC, Taverna D, Robinson SD, et al. (2002) Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nature medicine 8: 27-34.
31. Holmqvist K, Cross MJ, Rolny C, Hagerkvist R, Rahimi N, et al. (2004) The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration. J Biol Chem 279: 22267-22275.
32. Takahashi T, Yamaguchi S, Chida K, Shibuya M, (2001) A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J 20: 2768-2778.
33. Schaffner-Reckinger E, Gouon V, Melchior C, Plancon S, Kieffer N, (1998) Distinct involvement of beta3 integrin cytoplasmic domain tyrosine residues 747 and 759 in integrin-mediated cytoskeletal assembly and phosphotyrosine signaling. J Biol Chem 273: 12623-12632.
34. Czuchra A, Meyer H, Legate KR, Brakebusch C, Fassler R, (2006) Genetic analysis of beta1 integrin "activation motifs" in mice. J Cell Biol 174: 889-899.
35. Vallar L, Melchior C, Plancon S, Drobecq H, Lippens G, et al. (1999) Divalent cations differentially regulate integrin alphaIIb cytoplasmic tail binding to beta3 and to calcium- and integrin-binding protein. J Biol Chem 274: 17257-17266.
36. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, et al. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6: 277-293.
37. Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, et al. (2005) The CCPN data model for NMR Spectroscopy. Proteins 59: 687-696.
38. Wuthrich K, (1986) NMR of proteins and nucleic acids New York John Wiley & Sons.
39. Schwieters CD, Kuszewski JJ, Tjandra N, Clore GM, (2003) The Xplor-NIH NMR molecular structure determination package. J Magn Reson 160: 65-73.
40. Ward C, Kuehn D, Burden RE, Gormley JA, Jaquin TJ, et al. (2010) Antibody targeting of cathepsin S inhibits angiogenesis and synergistically enhances anti-VEGF. PLoS One 5.
41. Passaniti A, (1992) Extracellular matrix-cell interactions: Matrigel and complex cellular pattern formation. Lab Invest 67: 804; author reply 804-808.